Morbidity  ||| S:0 E:10 ||| NNP
and  ||| S:10 E:14 ||| CC
mortality  ||| S:14 E:24 ||| NN
of  ||| S:24 E:27 ||| IN
patients  ||| S:27 E:36 ||| NNS
with  ||| S:36 E:41 ||| IN
haemophilia  ||| S:41 E:53 ||| NN
in  ||| S:53 E:56 ||| IN
Germany  ||| S:56 E:64 ||| NNP
2007 ||| S:64 E:68 ||| CD
/ ||| S:68 E:69 ||| CD
2008  ||| S:69 E:74 ||| CD
Since  ||| S:74 E:80 ||| IN
1978  ||| S:80 E:85 ||| CD
an  ||| S:85 E:88 ||| DT
annual  ||| S:88 E:95 ||| JJ
multicentric  ||| S:95 E:108 ||| JJ
survey  ||| S:108 E:115 ||| NN
regarding  ||| S:115 E:125 ||| VBG
the  ||| S:125 E:129 ||| DT
epidemiology  ||| S:129 E:142 ||| NN
of  ||| S:142 E:145 ||| IN
patients  ||| S:145 E:154 ||| NNS
suffering  ||| S:154 E:164 ||| VBG
of  ||| S:164 E:167 ||| IN
haemophilia  ||| S:167 E:179 ||| NN
is  ||| S:179 E:182 ||| VBZ
performed  ||| S:182 E:192 ||| VBN
with  ||| S:192 E:197 ||| IN
support  ||| S:197 E:205 ||| NN
of  ||| S:205 E:208 ||| IN
haemophilia  ||| S:208 E:220 ||| NNS
treating  ||| S:220 E:229 ||| VBG
centres  ||| S:229 E:237 ||| NN
of  ||| S:237 E:240 ||| IN
any  ||| S:240 E:244 ||| DT
size ||| S:244 E:248 ||| NN
.  ||| S:248 E:250 ||| .
Again  ||| S:250 E:256 ||| RB
the  ||| S:256 E:260 ||| DT
actual  ||| S:260 E:267 ||| JJ
compilation  ||| S:267 E:279 ||| NN
is  ||| S:279 E:282 ||| VBZ
resting  ||| S:282 E:290 ||| VBN
upon  ||| S:290 E:295 ||| IN
a  ||| S:295 E:297 ||| DT
broad  ||| S:297 E:303 ||| JJ
database  ||| S:303 E:312 ||| NN
returning  ||| S:312 E:322 ||| VBG
to  ||| S:322 E:325 ||| TO
over  ||| S:325 E:330 ||| IN
30  ||| S:330 E:333 ||| CD
years  ||| S:333 E:339 ||| NNS
of  ||| S:339 E:342 ||| IN
inquiry  ||| S:342 E:350 ||| NN
well  ||| S:350 E:355 ||| RB
representing  ||| S:355 E:368 ||| VBG
both  ||| S:368 E:373 ||| PDT
the  ||| S:373 E:377 ||| DT
actual  ||| S:377 E:384 ||| JJ
and  ||| S:384 E:388 ||| CC
retrospective  ||| S:388 E:402 ||| JJ
status  ||| S:402 E:409 ||| NN
of  ||| S:409 E:412 ||| IN
mortality ||| S:412 E:421 ||| NN
.  ||| S:421 E:423 ||| .
Prompted  ||| S:423 E:432 ||| NNP
was  ||| S:432 E:436 ||| VBD
exclusively  ||| S:436 E:448 ||| RB
information  ||| S:448 E:460 ||| NN
about  ||| S:460 E:466 ||| IN
patients  ||| S:466 E:475 ||| NNS
with  ||| S:475 E:480 ||| IN
haemophilia  ||| S:480 E:492 ||| JJ
A ||| S:492 E:493 ||| NN
,  ||| S:493 E:495 ||| ,
B  ||| S:495 E:497 ||| NNP
and  ||| S:497 E:501 ||| CC
von  ||| S:501 E:505 ||| NNP
Willebrand  ||| S:505 E:516 ||| NNP
disease ||| S:516 E:523 ||| NN
.  ||| S:523 E:525 ||| .
In  ||| S:525 E:528 ||| IN
particular  ||| S:528 E:539 ||| JJ
anonymous  ||| S:539 E:549 ||| JJ
data  ||| S:549 E:554 ||| NNS
concerning  ||| S:554 E:565 ||| VBG
the  ||| S:565 E:569 ||| DT
last  ||| S:569 E:574 ||| JJ
12  ||| S:574 E:577 ||| CD
months  ||| S:577 E:584 ||| NNS
about  ||| S:584 E:590 ||| IN
number  ||| S:590 E:597 ||| NN
of  ||| S:597 E:600 ||| IN
treated  ||| S:600 E:608 ||| JJ
patients ||| S:608 E:616 ||| NNS
,  ||| S:616 E:618 ||| ,
type  ||| S:618 E:623 ||| NN
and  ||| S:623 E:627 ||| CC
severity  ||| S:627 E:636 ||| NN
of  ||| S:636 E:639 ||| IN
illness ||| S:639 E:646 ||| NN
,  ||| S:646 E:648 ||| ,
HIV-status  ||| S:648 E:659 ||| JJ
and  ||| S:659 E:663 ||| CC
detailed  ||| S:663 E:672 ||| JJ
information  ||| S:672 E:684 ||| NN
about  ||| S:684 E:690 ||| IN
causes  ||| S:690 E:697 ||| NNS
of  ||| S:697 E:700 ||| IN
death  ||| S:700 E:706 ||| NN
was  ||| S:706 E:710 ||| VBD
inquired ||| S:710 E:718 ||| VBN
.  ||| S:718 E:720 ||| .
This  ||| S:720 E:725 ||| DT
data  ||| S:725 E:730 ||| NNS
was  ||| S:730 E:734 ||| VBD
merged  ||| S:734 E:741 ||| VBN
with  ||| S:741 E:746 ||| IN
existing  ||| S:746 E:755 ||| VBG
data  ||| S:755 E:760 ||| NNS
and  ||| S:760 E:764 ||| CC
analyzed  ||| S:764 E:773 ||| VBD
statistically ||| S:773 E:786 ||| RB
.  ||| S:786 E:788 ||| .
In  ||| S:788 E:791 ||| IN
the  ||| S:791 E:795 ||| DT
2007 ||| S:795 E:799 ||| CD
/ ||| S:799 E:800 ||| CD
2008  ||| S:800 E:805 ||| CD
survey ||| S:805 E:811 ||| NN
,  ||| S:811 E:813 ||| ,
a  ||| S:813 E:815 ||| DT
total  ||| S:815 E:821 ||| JJ
number  ||| S:821 E:828 ||| NN
of  ||| S:828 E:831 ||| IN
8904  ||| S:831 E:836 ||| CD
patients  ||| S:836 E:845 ||| NNS
with  ||| S:845 E:850 ||| IN
bleeding  ||| S:850 E:859 ||| VBG
disorders  ||| S:859 E:869 ||| NNS
have  ||| S:869 E:874 ||| VBP
been  ||| S:874 E:879 ||| VBN
reported  ||| S:879 E:888 ||| VBN
from  ||| S:888 E:893 ||| IN
63  ||| S:893 E:896 ||| CD
participating  ||| S:896 E:910 ||| VBG
centres ||| S:910 E:917 ||| NNS
.  ||| S:917 E:919 ||| .
Despite  ||| S:919 E:927 ||| IN
mortality  ||| S:927 E:937 ||| NN
from  ||| S:937 E:942 ||| IN
HIV  ||| S:942 E:946 ||| NNP
in  ||| S:946 E:949 ||| IN
patients  ||| S:949 E:958 ||| NNS
with  ||| S:958 E:963 ||| IN
haemophilia  ||| S:963 E:975 ||| NN
is  ||| S:975 E:978 ||| VBZ
keeping  ||| S:978 E:986 ||| VBG
on  ||| S:986 E:989 ||| IN
decreasing ||| S:989 E:999 ||| VBG
,  ||| S:999 E:1001 ||| ,
HIV  ||| S:1001 E:1005 ||| NNP
still  ||| S:1005 E:1011 ||| RB
remains  ||| S:1011 E:1019 ||| VBZ
an  ||| S:1019 E:1022 ||| DT
important  ||| S:1022 E:1032 ||| JJ
factor  ||| S:1032 E:1039 ||| NN
as  ||| S:1039 E:1042 ||| IN
an  ||| S:1042 E:1045 ||| DT
HIV ||| S:1045 E:1048 ||| NNP
/ ||| S:1048 E:1049 ||| NNP
HCV  ||| S:1049 E:1053 ||| NNP
coinfection  ||| S:1053 E:1065 ||| NN
seems  ||| S:1065 E:1071 ||| VBZ
to  ||| S:1071 E:1074 ||| TO
increase  ||| S:1074 E:1083 ||| VB
risk  ||| S:1083 E:1088 ||| NN
of  ||| S:1088 E:1091 ||| IN
progression  ||| S:1091 E:1103 ||| NN
of  ||| S:1103 E:1106 ||| IN
severe  ||| S:1106 E:1113 ||| JJ
liver  ||| S:1113 E:1119 ||| NN
disease ||| S:1119 E:1126 ||| NN
.  ||| S:1126 E:1128 ||| .
Age  ||| S:1128 E:1132 ||| NN
structure  ||| S:1132 E:1142 ||| NN
in  ||| S:1142 E:1145 ||| IN
our  ||| S:1145 E:1149 ||| PRP$
patients  ||| S:1149 E:1158 ||| NNS
has  ||| S:1158 E:1162 ||| VBZ
been  ||| S:1162 E:1167 ||| VBN
shifting  ||| S:1167 E:1176 ||| VBG
significantly  ||| S:1176 E:1190 ||| RB
over  ||| S:1190 E:1195 ||| IN
the  ||| S:1195 E:1199 ||| DT
last  ||| S:1199 E:1204 ||| JJ
decades  ||| S:1204 E:1212 ||| NNS
bringing  ||| S:1212 E:1221 ||| VBG
age  ||| S:1221 E:1225 ||| NN
distribution  ||| S:1225 E:1238 ||| NN
into  ||| S:1238 E:1243 ||| IN
line  ||| S:1243 E:1248 ||| NN
with  ||| S:1248 E:1253 ||| IN
the  ||| S:1253 E:1257 ||| DT
entire  ||| S:1257 E:1264 ||| JJ
population ||| S:1264 E:1274 ||| NN
.  ||| S:1274 E:1276 ||| .
This  ||| S:1276 E:1281 ||| DT
has  ||| S:1281 E:1285 ||| VBZ
to  ||| S:1285 E:1288 ||| TO
be  ||| S:1288 E:1291 ||| VB
considered  ||| S:1291 E:1302 ||| VBN
assessing  ||| S:1302 E:1312 ||| VBG
mortality  ||| S:1312 E:1322 ||| NN
and  ||| S:1322 E:1326 ||| CC
morbidity ||| S:1326 E:1335 ||| NN
.  ||| S:1335 E:1337 ||| .
